|
ELP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.087600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.327400E-01 |
| Normal-vs-Stage2 |
2.304600E-01 |
| Normal-vs-Stage3 |
8.315200E-01 |
| Normal-vs-Stage4 |
7.158800E-01 |
| Stage1-vs-Stage2 |
9.832100E-02 |
| Stage1-vs-Stage3 |
7.991600E-01 |
| Stage1-vs-Stage4 |
9.826400E-01 |
| Stage2-vs-Stage3 |
1.289560E-01 |
| Stage2-vs-Stage4 |
1.488430E-01 |
| Stage3-vs-Stage4 |
8.651600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.999600E-01 |
| Normal-vs-AfricanAmerican |
1.114590E-01 |
| Normal-vs-Asian |
4.063200E-01 |
| Caucasian-vs-AfricanAmerican |
2.156200E-01 |
| Caucasian-vs-Asian |
6.330600E-01 |
| AfricanAmerican-vs-Asian |
4.162400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.008000E-01 |
| Normal-vs-Female |
5.898000E-01 |
| Male-vs-Female |
2.119600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.710400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.911600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.344800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.159400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.895430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.293600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.758200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.642000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.669000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.837000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.101000E-01 |
| Classical-VS-Follicular |
6.87905288287993E-12 |
| Classical-VS-Other |
2.998000E-01 |
| Classical-VS-Normal |
5.335600E-02 |
| Tall-VS-Follicular |
3.566100E-04 |
| Tall-VS-Other |
4.477800E-01 |
| Tall-VS-Normal |
4.243400E-01 |
| Follicular-VS-Other |
2.327200E-01 |
| Follicular-VS-Normal |
1.647710E-04 |
| Other-VS-Normal |
6.797600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.625200E-01 |
| Normal-vs-N1 |
7.051600E-01 |
| N0-vs-N1 |
7.624000E-01 |
|
|
